Table 3.
Peptide Ratios Measured by PRM in the Verification Cohort
Protein | Peptide sequence | p Value | NINDC vs CTRL | PINDC vs CTRL | INDC vs CTRL | ION vs CTRL | SC-CIS vs CTRL | FC-CIS vs CTRL | RRMS vs CTRL | PPMS vs CTRL | RRMS vs INDC | RRMS vs NINDC | RRMS vs ION | RRMS vs SC-CIS | RRMS vs FC-CIS | RRMS vs PPMS | SC-CIS vs FC-CIS |
CD138_1a | EGEAVVLPEVEPGLTA(R) | <0.0001 | 1.00 | 1.10 | 1.13 | 1.02 | 2.02* | 2.11* | 2.70*** | 2.29* | 2.38*** | 2.70*** | 2.65*** | 1.33 | 1.28 | 1.18 | 1.04 |
CD27_1a | HCNSGLLV(R) | <0.0001 | 1.32 | 1.35 | 3.66 | 1.19 | 5.63** | 6.61*** | 10.64*** | 5.16* | 2.91 | 8.06*** | 8.96*** | 1.89 | 1.61 | 2.06 | 1.17 |
CECR1_1a | LLPVYELSGEHHDEEWSV(K) | <0.0001 | 1.55 | 1.50 | 2.30* | 0.85 | 2.19* | 1.70* | 2.64*** | 1.44 | 1.15 | 1.70* | 3.11*** | 1.20 | 1.55 | 1.83 * | 0.78 |
CECR1_2a | SQVFNIL(R) | <0.0001 | 1.64 | 1.68 | 2.50* | 0.83 | 2.08 | 1.99 | 3.01*** | 1.67 | 1.21 | 1.84 | 3.61*** | 1.45 | 1.51 | 1.81 * | 0.96 |
CHI3L2_1a | LLLTAGVSAG(R) | <0.0001 | 1.80 | 1.30 | 2.69** | 1.18 | 1.76 | 1.84* | 2.90*** | 1.80 | 1.08 | 1.61 | 2.46*** | 1.64 | 1.57 | 1.61 | 1.05 |
CH3IL2_2a | GPSSYYNVEYAVGYWIH(K) | <0.0001 | 2.01 | 1.31 | 2.61 | 1.05 | 2.29 | 1.90 | 3.95*** | 1.98 | 1.51 | 1.96 | 3.74*** | 1.72 | 2.08 | 1.99 | 0.83 |
CHI3L1_1a | ILGQQVPYAT(K) | <0.0001 | 2.11 | 1.91 | 2.63** | 0.92 | 1.25 | 1.26 | 2.38*** | 2.00 | 0.91 | 1.13 | 2.58*** | 1.90 | 1.89 | 1.19 | 1.01 |
CHI3L1_3a | LVCYYTSWSQY(R) | 0.0002 | 2.60 | 1.64 | 1.62 | 0.58 | 1.15 | 1.30 | 2.46** | 1.53 | 1.52 | 0.95 | 4.22*** | 2.14 | 1.90 | 1.61 | 1.13 |
CHIT1_1a | VGAPATGSGTPGPFT(K) | <0.0001 | 4.88 * | 2.14 | 2.29 | 1.29 | 2.98 | 6.68*** | 9.82*** | 4.92 | 4.30 | 2.01 | 7.64*** | 3.30 | 1.47 | 2.00 | 2.25 |
CHIT1_3a | DNQWVGFDDVESF(K) | <0.0001 | 3.25 | 3.49 | 4.36 | 1.88 | 3.32 | 5.28** | 6.03*** | 4.35 | 1.38 | 1.85 | 3.20*** | 1.81 | 1.14 | 1.39 | 1.59 |
IGKC_1a | SGTASVVCLLNNFYP(R) | <0.0001 | 1.74 | 1.30 | 1.62 | 1.71 | 3.69 | 3.81 | 4.77*** | 3.40 | 2.94* | 2.74** | 2.79** | 1.29 | 1.25 | 1.40 | 1.03 |
IGKC_2a | VDNALQSGNSQESVTEQDS(K) | <0.0001 | 1.16 | 1.41 | 1.56 | 1.30 | 2.74** | 2.62** | 4.54*** | 2.92* | 2.92** | 3.91*** | 3.50*** | 1.66 | 1.73 | 1.55 | 0.96 |
CFHR1_3b | INHGILYDEE(K) | 0.0650 | 1.25 | 1.89 * | 1.19 | 1.16 | 0.90 | 0.83 | 0.82 | 1.17 | 0.68 | 0.65 | 0.70 | 0.91 | 0.98 | 0.69 | 0.93 |
RELN_2b | VIVLLPQ(K) | 0.4867 | 0.70 | 1.19 | 1.03 | 1.34 | 1.16 | 0.98 | 0.90 | 1.35 | 0.87 | 1.29 | 0.67 | 0.77 | 0.92 | 0.66 | 0.84 |
LYZ_1c | WESGYNT(R) | <0.0001 | 1.20 | 1.24 | 2.03 | 0.58 | 0.89 | 0.83 | 1.43 | 0.84 | 0.70 | 1.19 | 2.45*** | 1.60 | 1.73 | 1.70 * | 0.93 |
NGAL_1c | SYPGLTSYLV(R) | 0.0154 | 1.27 | 1.32 | 1.55* | 0.93 | 0.94 | 0.90 | 1.10 | 1.02 | 0.71 | 0.87 | 1.18 | 1.18 | 1.23 | 1.08 | 0.96 |
Fold changes among the different group comparisons of the 16 peptides quantified by PRM in the verification cohort. Statistical difference between the different cohorts was assessed by the Kruskal-Wallis test (p values for each peptide listed in column 3) followed by the Dunn multiple comparison test (*p value <0.05; **p-value <0.01; ***p value <0.001) using GraphPad PRISM 10.1.0. a and b indicate peptides originating from proteins identified as significant in CSF proteomic analysis comparing CTRL with RRMS and FC-CIS with SC-CIS, respectively. c indicates proteins identified as significant upon TNFα exposure in OPC secretome analysis (see also eTable 4).